Xconomy’s Digital Events →
John Flannery was named CEO and chairman of GE in 2017. Photo courtesy of GE.
Sponsored · Whitepaper
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
From Our Editors · Podcast
Becoming the Cell & Gene Therapy Hub
© 2007-2022, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.